Raaj Medisafe India Ltd Stock Price Today (NSE: RAAJMEDI)
Fundamental Score
Raaj Medisafe India Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Raaj Medisafe India Ltd share price today is ₹85.64, up +0.00% on NSE/BSE as of 17 February 2026. Raaj Medisafe India Ltd (RAAJMEDI) is a Small-cap company in the Packaging sector with a market capitalisation of ₹90.83 (Cr). The 52-week high for RAAJMEDI share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 11.80x, RAAJMEDI is currently trading below its industry average P/E of 21.55x. The company has a Return on Equity (ROE) of 32.48% and a debt-to-equity ratio of 1.79.
Raaj Medisafe India Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Raaj Medisafe India Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Raaj Medisafe Share Price Analysis: ROCE Efficiency and Competitive Moat
The packaging industry, particularly for pharmaceuticals and food, is witnessing a surge in demand for sustainable and high-barrier solutions. This trend directly impacts companies like Raaj Medisafe India Ltd. This financial analysis examines the current status of Raaj Medisafe share price (₹91.0) in relation to its profitability and efficiency. The observed Price-to-Earnings (PE) ratio stands at 11.8, a key metric for gauging market valuation. The analysis forms part of a wider 80-parameter fundamental audit verified by Sweta Mishra, aiming to provide a deeper understanding of the company's financial health.
A crucial element driving Raaj Medisafe's attractiveness is its Return on Capital Employed (ROCE) of 15.02%. ROCE indicates how effectively the company generates profit from its capital investments. A higher ROCE generally suggests better management and operational efficiency. This 15.02% ROCE contributes to building a sustainable competitive moat for Raaj Medisafe. It enables the company to reinvest profits, potentially expanding operations, developing new products, or acquiring new technologies, all without excessively relying on external financing.
When benchmarked against sector peers, differences emerge. For example, consider
Subam Papers Ltd. While detailed qualitative information on Subam Papers Ltd's management quality would require further investigation, observing and comparing metrics like employee retention rate, stakeholder relationships, and strategic execution across different companies often provides insights into the overall effectiveness of their respective management teams. Such qualitative evaluations are inherently subjective and best derived from thorough due diligence.The observed ROCE for Raaj Medisafe suggests that it is deploying capital more efficiently than many of its peers. However, continued monitoring of this metric is essential. A sustained ROCE above the company's cost of capital is a strong indicator of long-term value creation. Further analysis including debt levels, growth trajectory, and detailed cash flow statements is recommended for a comprehensive evaluation. This analysis uses factual observations; no buy/sell recommendations are made.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Raaj Medisafe India Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of RAAJMEDI across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (32.48%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (15.02%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 11.80 vs Industry: 21.55)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (78.35%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (68.65%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (23.42% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (47.93% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (72.62% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (73.80%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Elevated Debt Levels (D/E: 1.79)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Negative Free Cash Flow (₹-21.19 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Raaj Medisafe India Ltd Financial Statements
Comprehensive financial data for Raaj Medisafe India Ltd including income statement, balance sheet and cash flow
About RAAJMEDI (Raaj Medisafe India Ltd)
Raaj Medisafe India Ltd (RAAJMEDI) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Packaging sector with a current market capitalisation of ₹90.83 (Cr). Raaj Medisafe India Ltd has delivered a Return on Equity (ROE) of 32.48% and a ROCE of 15.02%. The debt-to-equity ratio stands at 1.79, reflecting the company's capital structure. Investors tracking RAAJMEDI share price can monitor key metrics including P/E ratio, promoter holding of 73.80%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
RAAJMEDI Share Price: Frequently Asked Questions
What is the current share price of Raaj Medisafe India Ltd (RAAJMEDI)?
As of 17 Feb 2026, 10:19 am IST, Raaj Medisafe India Ltd share price is ₹85.64. The RAAJMEDI stock has a market capitalisation of ₹90.83 (Cr) on NSE/BSE.
Is RAAJMEDI share price Overvalued or Undervalued?
RAAJMEDI share price is currently trading at a P/E ratio of 11.80x, compared to the industry average of 21.55x. Based on this relative valuation, the Raaj Medisafe India Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of RAAJMEDI share price?
The 52-week high of RAAJMEDI share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Raaj Medisafe India Ltd share price?
Key factors influencing RAAJMEDI share price include quarterly earnings growth (Sales Growth: 68.65%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Raaj Medisafe India Ltd a good stock for long-term investment?
Raaj Medisafe India Ltd shows a 5-year Profit Growth of 72.62% and an ROE of 32.48%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.79 before investing in RAAJMEDI shares.
How does Raaj Medisafe India Ltd compare with its industry peers?
Raaj Medisafe India Ltd competes with major peers in the Packaging. Investors should compare RAAJMEDI share price P/E of 11.80x and ROE of 32.48% against the industry averages to determine competitive standing.
What is the P/E ratio of RAAJMEDI and what does it mean?
RAAJMEDI share price has a P/E ratio of 11.80x compared to the industry average of 21.55x. Investors pay ₹12 for every ₹1 of annual earnings.
How is RAAJMEDI performing according to Bull Run's analysis?
RAAJMEDI has a Bull Run fundamental score of 69/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does RAAJMEDI belong to?
RAAJMEDI operates in the Packaging industry. This classification helps understand the competitive landscape and sector-specific trends affecting Raaj Medisafe India Ltd share price.
What is Return on Equity (ROE) and why is it important for RAAJMEDI?
RAAJMEDI has an ROE of 32.48%, which indicates excellent management efficiency. ROE measures how efficiently Raaj Medisafe India Ltd generates profits from shareholders capital.
How is RAAJMEDI debt-to-equity ratio and what does it indicate?
RAAJMEDI has a debt-to-equity ratio of 1.79, which indicates high leverage that increases financial risk.
What is RAAJMEDI dividend yield and is it a good dividend stock?
RAAJMEDI offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Raaj Medisafe India Ltd shares.
How has RAAJMEDI share price grown over the past 5 years?
RAAJMEDI has achieved 5-year growth rates of: Sales Growth 23.42%, Profit Growth 72.62%, and EPS Growth 47.93%.
What is the promoter holding in RAAJMEDI and why does it matter?
Promoters hold 73.80% of RAAJMEDI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Raaj Medisafe India Ltd.
What is RAAJMEDI market capitalisation category?
RAAJMEDI has a market capitalisation of ₹91 crores, placing it in the Small-cap category.
How volatile is RAAJMEDI stock?
RAAJMEDI has a beta of N/A. A beta > 1 suggests the Raaj Medisafe India Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is RAAJMEDI operating profit margin trend?
RAAJMEDI has a 5-year average Operating Profit Margin (OPM) of 14.24%, indicating the company's operational efficiency.
How is RAAJMEDI quarterly performance?
Recent quarterly performance shows Raaj Medisafe India Ltd YoY Sales Growth of 68.65% and YoY Profit Growth of 78.35%.
What is the institutional holding pattern in RAAJMEDI?
RAAJMEDI has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Raaj Medisafe India Ltd stock.